1. Strand, F. L. (2003) Neuropeptides: General characteristics and neuropharmaceutical potential in treating CNS disorders Prog Drug Res
61, 1–37.
2. Gainetdinov, R. R., Wetsel, W. C., Jones, S. R., Levin, E. D., Jaber, M., and Caron, M. G. (1999) Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity Science
283, 397–401.
3. Xu, F., Gainetdinov, R. R., Wetsel, W. C., Jones, S. R., Bohn, L. M., Miller, G. W., Wang, Y. M., and Caron, M. G. (2000) Supersensitivity to psychostimulants in mice lacking the noradrenaline transporter Nature Neurosci
3, 465–71.
4. Ribar, T. J., Rodriguiz, R. M., Khiroug, L., Wetsel, W. C., Augustine, G. J., and Means, A. R. (2000) Cerebellar deficits in Ca2+/Calmodulin kinase IV-deficient mice J Neurosci
20(RC107), 1–5.
5. Nillni, E. A., Xie, W., Mulcahy, L., Sanchez, V. C., and Wetsel, W. C. (2002) Deficiencies in pro-thyrotropin-releasing hormone (pro-TRH) processing and abnormalities in thermoregulation in Cpe
fat/fat
mice J Biol Chem
277, 48587–95.